3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

Autor: Daniela Carbone, Godefridus J. Peters, Ugo Perricone, Elisa Giovannetti, Btissame El Hassouni, Girolamo Cirrincione, Giovanna Li Petri, Barbara Parrino, Stella Cascioferro, Vincenzo Arizza, Patrizia Diana, Niccola Funel, Alessandro Padova
Přispěvatelé: Medical oncology laboratory, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer biology and immunology, Cascioferro S., Li Petri G., Parrino B., El Hassouni B., Carbone D., Arizza V., Perricone U., Padova A., Funel N., Peters G.J., Cirrincione G., Giovannetti E., Diana P.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Molecules, 25(2):329. Multidisciplinary Digital Publishing Institute
Molecules, Vol 25, Iss 2, p 329 (2020)
Molecules
Volume 25
Issue 2
Cascioferro, S, Li Petri, G, Parrino, B, el Hassouni, B, Carbone, D, Arizza, V, Perricone, U, Padova, A, Funel, N, Peters, G J, Cirrincione, G, Giovannetti, E & Diana, P 2020, ' 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma ', Molecules, vol. 25, no. 2, 329 . https://doi.org/10.3390/molecules25020329
ISSN: 1420-3049
DOI: 10.3390/molecules25020329
Popis: A new series of imidazo[2,1-b][1,3,4]thiadiazole derivatives was efficiently synthesized and screened for their in vitro antiproliferative activity on a panel of pancreatic ductal adenocarcinoma (PDAC) cells, including SUIT-2, Capan-1 and Panc-1. Compounds 9c and 9l, showed relevant in vitro antiproliferative activity on all three pre-clinical models with half maximal inhibitory concentration (IC50) ranging from 5.11 to 10.8 µ
M, while the compounds 9e and 9n were active in at least one cell line. In addition, compound 9c significantly inhibited the migration rate of SUIT-2 and Capan-1 cells in the scratch wound-healing assay. In conclusion, our results will support further studies to increase the library of imidazo [2,1-b][1,3,4] thiadiazole derivatives for deeper understanding of the relationship between biological activity of the compounds and their structures in the development of new antitumor compounds against pancreatic diseases.
Databáze: OpenAIRE